Nadine Abi-Jaoudeh

Zachary T. Berman, MD is an Associate Professor of Clinical Radiology at the University of California, San Diego, with a subspecialty focus in interventional oncology and hepatobiliary malignancies. A graduate of Case Western Reserve University School of Medicine, Dr. Berman completed his internal medicine internship and diagnostic/interventional radiology residency at UC San Diego. He now serves as a national thought leader in liver-directed therapy and interventional radiology.

Venkatesh (Kavi) Krishnasamy is the Director of Interventional Oncology and Interventional Research at the University of Alabama Birmingham. His clinical focus is primarily the full gamut of Interventional Oncology and MSK/pain interventions. In particular, he specializes in complex percutaneous ablation and transarterial therapies with adjunctive techniques. His academic interests include device/software development, translational research, and multidisciplinary oncology trials. He additionally focuses on therapeutic guideline and algorithm development.

William S. Rilling, MD, FSIR, is a Tenured Professor of Radiology and Surgery at the Medical College of Wisconsin. He completed his diagnostic radiology residency at the Medical College of Wisconsin and his fellowship in Vascular and Interventional Radiology at Northwestern University in Chicago in 1996. He has been practicing at the Medical College of Wisconsin since 1996 and is the Vice Chair of Clinical Operations in Radiology and is also the former Division Chief of Vascular and Interventional Radiology, a role he held for 14 years.

Dr. Rilling has served on the Executive Council for the Society of Interventional Radiology (SIR), the Board of Directors for World Congress of Interventional Oncology (WCIO), SIR Foundation, and Society of Interventional Oncology (SIO). As Education Councilor for SIR, he co-directed the first three professional education meetings dedicated to Interventional Oncology, beginning in 2002. He has also served as the annual meeting chair for both SIR and WCIO and is the past-president for the Society of Interventional Oncology (SIO). He has served as local and national principal investigator for several important IO trials and is currently active as a consultant for several companies working to improve outcomes in IO.

Ahmed Kamel Abdel Aal, MD, PhD, FSIR is Professor of Radiology and Internal medicine, Chief of Vascular and Interventional Radiology and Vice Chair of Radiology at the University of Texas Health Science Center in Houston, and Director of Interventional Radiology at LBJ Hospital in Houston. Dr. Kamel is American board certified in Radiology and Interventional Radiology. He received fellowship training in Vascular and Interventional Radiology as well as Neuroradiology at University of Alabama at Birmingham. Dr. Kamel holds Masters of Science and PhD degrees in Radiology. He was awarded the “Top ten faculty award for excellence in resident education”, the “Certificate of Merit Award” from the Radiological Society of North America, the “Certificate of Merit Award” from the American Roentgen Ray Society, the “Certificate of Outstanding performance in Veterans Affairs Radiology Service” and the “Louisville Slugger Award for best Board reviewer”. His areas of clinical interest are Dialysis interventions, Interventional Oncology, Arterial disease interventions, Spine interventions and DVT management.

Dr. Chapiro is a ABR-certified Diagnostic and Interventional Radiologist and an Associate Professor of Radiology, Digestive Diseases (Hepatology) and of Biomedical Engineering. He is the Principal Investigator of the Yale Interventional Oncology Research Lab and Director of the Center for Minimally Invasive Therapies. Dr. Chapiro’s research focuses on developing new quantitative imaging biomarkers for the diagnosis, characterization, and therapeutic management of liver cancer. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence solutions for the management of liver cancer. His basic research interest mainly focuses on developing new tools to characterize the tumor microenvironment and the immune system in the setting of loco-regional, image-guided therapies of liver cancer. He authored and co-authored >180 original research articles, reviews and book chapters and gave more than 150 talks and invited lectures at national and international forums within the last seven years including in Europe, China, South Korea and the Middle East. Dr. Chapiro is an Editorial Board member of the Journal of Hepatology (EASL), Radiology and Radiology: AI (RSNA), Journal of Vascular and Interventional Radiology (SIR) and Cardiovascular and Interventional Radiology: Oncology (CIRSE). He chairs the Research Committee of the Society of Interventional Oncology and chaired the Annual Meeting Program Planning Committee for the Subspecialty of Interventional Radiology at the Annual Radiological Society of North America meeting 2021-2023. He is the co-initiator of the "Rising Star" Student Exchange Program in collaboration with the Charité University Hospital in Berlin.

A member of the Miami Cardiac & Vascular Institute and Miami Cancer Institute physician team, Dr. Gandhi specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases.

Dr. Gandhi did his undergraduate studies at Northwestern University and Harvard University. He graduated summa cum laude. He received his degree in medicine from Northwestern University Medical School, where he also graduated with honors. Following medical school, he completed a surgical internship at Cornell University Medical Center and New York Presbyterian Hospital. He completed his residency training and fellowship at UCLA Medical Center.

Dr. Gandhi also dedicated an entire year to biomedical research at Memorial Sloan-Kettering Cancer Center and also served as a research fellow at the National Institutes of Health (NIH). Prior to joining Miami Cardiac & Vascular Institute, he was an international visiting scholar at Asan Medical Center/University of Ulsan Medical School in Seoul, South Korea. He has published numerous scientific papers, authored several textbook chapters and presented his research at national and international meetings.

He is also a fellow of the Society for Vascular Medicine and a fellow of the Society of Interventional Radiology. He is the co-author of the textbook Interventional Oncology. Dr. Gandhi is also a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Edgar St. Amour is an interventional radiologist with Central Arkansas Radiation Therapy Institute (CARTI), a multidisciplinary outpatient oncology practice. He provides interventional oncology services in the OBL and ASC setting.

Chief of Interventional Radiology, Mass General Brigham; Associate Professor, Harvard Medical School.
Introduced cryoablation ablations at MGH. Involved in liver, kidney and soft tissue ablations for pain control. Has published articles in renal interventions including renal and adrenal ablations. Organized ablation workshops nationally and internatinally which included lectures, panel discussions, and live demonstration workshops for liver tumor ablation. Invited speaker and moderator for multiple conferences including SIR, ARRS, SIO and CIO. Has also led projects and preseented talks related to Machine Learning and application of mixed reality in Interventional Radiology.

Chief of Interventional Radiology, Mass General Brigham; Associate Professor, Harvard Medical School.
Introduced cryoablation ablations at MGH. Involved in liver, kidney and soft tissue ablations for pain control. Has published articles in renal interventions including renal and adrenal ablations. Organized ablation workshops nationally and internatinally which included lectures, panel discussions, and live demonstration workshops for liver tumor ablation. Invited speaker and moderator for multiple conferences including SIR, ARRS, SIO and CIO. Has also led projects and preseented talks related to Machine Learning and application of mixed reality in Interventional Radiology.

Dr. Abi-Jaoudeh is an American and Canadian board-certified vascular and interventional radiologist at the University of California Irvine. Dr. Abi-Jaoudeh earned her medical degree from the University of Montreal and completed internship and residency at the University of Laval in Québec, Canada a fellowship in interventional radiology at the University of Virginia in Charlottesville, Va. She then joined National Institutes of Health where she was a principal and associate investigator on several human trials. She also completed multiple animal and translational studies. In 2015, Dr. Abi-Jaoudeh joined the University of California Irvine where she has grown the research program. In 2018, she became the director of Clinical research of the department of Radiology and in 2020 she became the chief of Interventional radiology section. She is principal investigator on multiple Phase I, II and III trials.
She has authored multiple manuscripts and submitted two patents related to imaging technology in the angiography suite. Her research interests include fusion and functional imaging during image guided procedures, innovative therapeutic methods to treat metastatic and primary liver disease. Her goal is to grow a translational research program to improve UCI patient care and outcome.
Dr Abi-Jaoudeh is a fellow of the Society of Interventional Radiology, a member of the Royal Canadian College of Radiology. She has served as deputy editor of the Journal of Vascular and Interventional Radiology and on the scientific committee of the Society of Interventional Radiology annual meeting and the chair of the clinical trials and registries committees.

Doctor Iqbal is an Interventional Radiologist at the Massachusetts General Hospital and serves as the Director for quality & safety for Interventional Radiology. Shams is passionate about finding new techniques to help patients get the best care possible across IR. He developed a new technique for Intraoperative localization of small lung nodule at surgery decreasing morbidity and increasing safety and accuracy. He is the chairman of the “SIR give back program” and helps Interventional Radiology programs across the globe. He is the Leader for SIR Global educational initiative. His basic research is in nanotechnology techniques for early diagnosis of cancers and metastases, focusing on cholangiocarcinoma. He is working on device development, with devices in the pipeline for gastroparesis management by neuromodulation. His overarching goal is to provide good quality Interventional Radiology training and IR care to patients across the globe and find early diagnosis of cancers to prolong patient survival.